Elena Zaffignani

Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial

Paolo Marchetti, Giuseppe Curigliano, Mauro Biffoni, Sara Lonardi et autres

Despite recent advancements demonstrating the potential of tumor-agnostic biomarkers to guide effective therapies, randomized evidence supporting the clinical superiority of precision oncology approaches compared to standard therapies remains limited. The ROME trial was a multicenter, randomized, open-label phase 2 study comparing tailored …

it, us, br (code pays fourni par la source)

Author response for "Comparing Combination vs Monochemotherapy in Late-Elderly Patients With Advanced Pancreatic Cancer: Insights From a Single-Center Study"

Elena Orlandi, Chiara Citterio, Rebecca Chinelli, Elena Zaffignani et autres

Comparing Combination vs Monochemotherapy in Late-Elderly Patients With Advanced Pancreatic Cancer: Insights From a Single-Center Study

Elena Orlandi, Chiara Citterio, Rebecca Chinelli, Elena Zaffignani et autres

Objectives The incidence of pancreatic ductal adenocarcinoma (PDAC) increases with age and is frequently diagnosed at an inoperable stage, which limits treatment options. There is limited evidence concerning patients over 75 years old, and clinical practice often lacks clear guidance regarding the …

it (code pays fourni par la source)

The Importance of Telemedicine for Cancer Patients during the COVID-19 Pandemic

Luigi Cavanna, Chiara Citterio, Camilla Di Nunzio, Elisa Anselmi et autres

It is well known that SARS-COV-2 can cause serious complications for most frail patients, including oncologic patients. The COVID-19 pandemic has severely affected the management of cancer patients, and telemedicine services during the COVID-19 pandemic have become essential to reduce the risk …

Management of Cancer Patients during the COVID-19 Pandemic

Luigi Cavanna, Chiara Citterio, Elena Zaffignani, Massimo Ambroggi et autres

In December 2019, a new pathogen-enveloped RNA betacoronavirus has been identified and named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which causes severe pulmonary disease in 14% of infected people. The WHO has declared coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, a …

COVID-19 Vaccination in Cancer Patients Older Than 70 Years Undergoing Active Treatment. Seroconversion Rate and Safety

Luigi Cavanna, Manuela Proietto, Chiara Citterio, Elisa Anselmi et autres

Patients with cancer have a high risk of intubation, intensive care unit admission, or death from the coronavirus disease (COVID-19); age and comorbidities are additional risk factors. Vaccination is effective against COVID-19; however, patients with cancer have been excluded from pivotal clinical …

it (code pays fourni par la source)

Le cure oncologiche ed ematologiche sul territorio secondo il modello dell’ASL di Piacenza. Rendiconto di 4 anni consecutivi

Luigi Cavanna, Chiara Citterio, Camilla Di Nunzio, Elena Zaffignani et autres

INTRODUCTION: The natural history of cancer has radically changed in the last decade. The burden of travel from patient's residence to health care providers is an important issue that can influence access to diagnosis and treatment of cancer; however this issue is …

it (code pays fourni par la source)

A Rare Case of Coronavirus Disease 2019 Survival in an Elderly Patient With Atheroembolic Renal Disease

Luigi Cavanna, Elena Zaffignani, Chiara Citterio, Sara De Amicis et autres

Atheroembolic renal disease (AERD) is a life-threatening illness. Coronavirus disease 2019 (COVID-19) has a high mortality rate in older patients with comorbidities. We report the case of severe-type COVID-19 in an 82-year-old female with AERD. She was treated with hydroxychloroquine-based therapy and …

it (code pays fourni par la source)

Coronavirus Disease-2019 in Cancer Patients. A Report of the First 25 Cancer Patients in a Western Country (Italy)

Elisa Maria Stroppa, Ilaria Toscani, Chiara Citterio, Elisa Anselmi et autres

Background: We describe cancer patients with coronavirus disease-2019 (COVID-19) infection treated at the Piacenza’s general hospital (north Italy). Materials & methods: 25 cancer patients infected by COVID-19 admitted at the Piacenza’s general hospital from 21 February to 18 March 2020. Outcome from …

it (code pays fourni par la source)

Internet in oncology: a new way to improve communication and information?

Camilla Di Nunzio, Patrizia Mordenti, Chiara Citterio, Elena Zaffignani et autres

it (code pays fourni par la source)

Surgery and the elderly: when an apparent overtreatment becomes safe and effective

Patrizia Mordenti, Silvia Lucchini, Elena Zaffignani, D.L. Capuano et autres

it (code pays fourni par la source)

FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution experience

Elisa Maria Stroppa, Elena Orlandi, Stefano Vecchia, Flavio Cesare Bodini et autres

it (code pays fourni par la source)